Dan Xu
Chiba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Flexible Polymer-Based Electronics for Human Health Monitoring: A Safety-Level-Oriented Review of Materials and Applications.
Journal: Nano-micro letters
Published: October 03, 2025
Dietary sulforaphane glucosinolate alleviates stress-induced depression and demyelination through gut-brain axis modulation.
Journal: The Journal of nutritional biochemistry
Published: August 28, 2025
Spleen-brain axis regulates myelin integrity via TGF-β1 signaling in cuprizone-induced demyelination and remyelination model.
Journal: European journal of pharmacology
Published: July 23, 2025
Subdiaphragmatic vagotomy reduces hypothalamic oxytocin expression and blood levels after oral MDMA administration in male rats.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: November 24, 2024
Repeated intermittent administration of 3,4-methylenedioxymethamphetamine mitigates demyelination in the brain from cuprizone-treated mice.
Journal: European journal of pharmacology
Published: November 16, 2024
Effects of 3,4-methylenedioxymethamphetamine on the gut microbiota and metabolites in the small intestine, cecum, and colon of male rats.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: October 21, 2024
Arketamine alleviates cognitive impairments and demyelination in mice with postoperative cognitive dysfunction via TGF-β1 activation.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: October 08, 2024
Splenic γδ T cells mediate antidepressant and prophylactic actions of arketamine in lipopolysaccharide-induced depression in mice.
Journal: Pharmacology, biochemistry, and behavior
Published: October 01, 2024
Microbiome depletion by broad-spectrum antibiotics does not influence demyelination and remyelination in cuprizone-treated mice.
Journal: Pharmacology, biochemistry, and behavior
Published: August 26, 2024
Transforming growth factor-β1 mediates the beneficial effects of arketamine on demyelination and remyelination in the brains of cuprizone-treated mice.
Journal: European journal of pharmacology
Published: August 14, 2024
Effects of arketamine on depression-like behaviors and demyelination in mice exposed to chronic restrain stress: A role of transforming growth factor-β1.
Journal: Journal of affective disorders
Published: May 30, 2024
Last Updated: 09/26/2026